Clinical trial Recruiting at 1 site Interventional Ages 60 Months to 215 Months

Home initiation of breathing support for children with complex medical needs

Official title: Single Site Feasibility and Safety Study of Home Initiation of Noninvasive Positive Pressure Ventilation in Children With Medical Complexity

Run by The Hospital for Sick Children · NCT05881031 · Data updated 2026-11-12

This study is testing if starting breathing support at home for children with complex medical needs is safe and effective compared to starting it in the hospital.

More Sleep-Disordered Breathing trials

Quick facts

Study typeInterventional
Ages60 Months to 215 Months
SexAll
Enrollment24 (estimated)
SponsorThe Hospital for Sick Children
Academic / other
Locations1 site (Toronto, Ontario)
StatusRecruiting
StartedJune 21, 2023
Main results expectedDecember 1, 2026
Study endsDecember 1, 2027
Registry record updatedMay 7, 2026
Trial IDNCT05881031 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 5-17 years with medical complexity who have been newly prescribed NiPPV and can tolerate an awake trial of the device.

Probably not a fit

Patients with severe cardiac disease, high risk of complications from NiPPV, or severe sleep-disordered breathing may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the feasibility and safety of starting noninvasive positive pressure ventilation (NiPPV) for children with medical complexity (CMC) in their home environment, rather than in a hospital setting. The research involves randomly assigning participants to either home initiation of NiPPV with remote telemonitoring or the standard in-hospital polysomnography (PSG) method. By assessing the effectiveness of this innovative approach, the study aims to improve adherence to NiPPV and enhance the quality of life for CMC. The study focuses on children aged 5-17 years who are newly prescribed NiPPV and have tolerated an awake trial of the device.

Why it matters

Potential benefit: If successful, this approach could significantly improve the comfort and adherence of children using breathing support, leading to better health outcomes.

How similar studies have gone: While the standard initiation of NiPPV typically occurs in a hospital, this home-based approach is innovative and has not been widely tested in similar studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age 5-17 years old
2. Newly prescribed NiPPV
3. Tolerated awake NiPPV trial
4. Provides informed consent

Exclusion Criteria:

1. Cardiac disease at risk of hemodynamic instability with NiPPV initiation (eg cardiac dysfunction (ejection fraction \<45%), pulmonary hypertension (mean pulmonary artery pressure ≥ 20 mmHg on right heart catheterization or suggestive echocardiogram findings in the opinion of a pediatric cardiologist), or single ventricle)
2. At high risk of complications with NiPPV in the opinion of the child's physician (eg pneumothorax and aspiration risk)
3. Severe sleep disordered breathing with peak CO2 ≥ 60mmHg or apnea-hypopnea index (AHI)≥ 30/hr (AHI measures the number of respiratory events per hour)
4. Participation in concurrent research study that may affect NiPPV adherence (proposed primary outcome of full study)
5. Exclusion of study participants if the caregiver or participant is not English speaking

Where it's running

  • The Hospital for Sick Children
    Toronto, Ontario, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.